Andrea S. Lukes

ORCID: 0000-0002-3500-6731 · 11 papers in corpus · active 2005-2022

Study types

  • article 9
  • book-chapter 1
  • letter 1

Condition tags

  • adenomyosis 4
  • endometriosis 1
article 2022
TIME TO MINIMAL OR NO PELVIC PAIN WITH RELUGOLIX COMBINATION THERAPY IN WOMEN WITH ENDOMETRIOSIS-ASSOCIATED PAIN: RESULTS FROM THE SPIRIT PROGRAM
·doi:10.1016/j.fertnstert.2022.08.035
article 2018
Efficacy and safety of elagolix in a subgroup of women with uterine fibroids and adenomyosis: results from a phase 2 trial
·doi:10.1016/j.fertnstert.2018.07.186
article 2018
Efficacy and Safety of Elagolix in a Subgroup of Women with Uterine Fibroids and Adenomyosis: Results from a Phase 2 Trial
·doi:10.1016/j.jmig.2018.09.175
article 2017
Experience of Symptoms and Disease Impact in Patients with Adenomyosis
The patient ·doi:10.1007/s40271-017-0284-2

BACKGROUND: Adenomyosis is a poorly understood, benign disease of the uterus. OBJECTIVE: In this study, patient interviews were conducted to characterize the symptoms and impact of adenomyosis. METHODS: This was a cross-sectional study in w…

letter 2015
Postablation Risk Factors for Pain and Subsequent Hysterectomy
·doi:10.1097/aog.0000000000000767

Carolina Women's Research and Wellness Center, Durham, North Carolina Financial Disclosure The author did not report any potential conflicts of interest. Dr. Lukes is a current PI on an AEGEA clinical trial for endometrial ablations, and ga…

article 2010
Novel, oral tranexamic acid improves the general quality of life (SF-36v2™ health survey measures) in women with menorrhagia
·doi:10.1016/j.fertnstert.2010.07.809
article 2009
Potential clinical applications of uterine artery occlusion
·doi:10.1586/eog.09.36

Leiomyomata uteri remain a common gynecologic problem, associated with a significant clinical and economic burden of illness. Despite a variety of currently available interventions for uterine fibroids, there remains an unmet clinical need …

book-chapter 2008
Endometrial cryoablation
·doi:10.3109/9780203091524-28

The challenge for all endometrial ablation technologies is the unique and impressive ability of the endometrium to regenerate. The endometrium is predominantly an endocrine organ that responds to a sequence of orchestrated hormonal signals …

article 2007
A Multi-Site, Prospective Cross-Over Study of Intranasal Desmopressin and Oral Tranexamic Acid in Women with Menorrhagia and Abnormal Laboratory Hemostasis.
·doi:10.1182/blood.v110.11.711.711

Introduction: Menorrhagia is a common health problem affecting ∼5-10% of women. The optimal management of menorrhagia among women with abnormal laboratory hemostasis is uncertain. The goal of this study was to determine the effect of intran…

article 2005
191
·doi:10.1016/j.jmig.2005.07.190
article 2005
213
·doi:10.1016/j.jmig.2005.07.211